Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
How to Build a Marketing Ecosystem, Not Just Run Campaigns
Most pharma companies in India are still chasing campaigns. Monthly plans, burst tactics, launch calendars: then rinse and repeat. But let’s be honest. Campaigns aren’t enough anymore. Not in 2025.…
|
If Your Platform Doesn’t Know Schedule H, You’re in Trouble
Every pharma marketing agency wants your attention. They pitch multichannel campaigns, dashboards, and digital wizardry. But here’s the thing: if the platform they’re pushing doesn’t understand…
|
Digital Maturity vs. Marketing Velocity: Where Indian Pharma is Stuck
Indian pharma is caught in a strange paradox. Over the last five years, there’s been steady investment in digital infrastructure through CRMs, rep enablement tools, marketing automation, and…
|
The Quiet Power of Rep‑Triggered Campaigns
If you’re a pharma CMO in India, you’ve seen the slowdown: field reps visiting the same doctors, digital campaigns that don’t land, and ROI that feels stuck. You think you’re doing enough, but you’re…
